Does DUPILUMAB Cause Product dose omission issue? 18,189 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18,189 reports of Product dose omission issue have been filed in association with DUPILUMAB (Dupixent). This represents 4.8% of all adverse event reports for DUPILUMAB.
18,189
Reports of Product dose omission issue with DUPILUMAB
4.8%
of all DUPILUMAB reports
21
Deaths
598
Hospitalizations
How Dangerous Is Product dose omission issue From DUPILUMAB?
Of the 18,189 reports, 21 (0.1%) resulted in death, 598 (3.3%) required hospitalization, and 10 (0.1%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DUPILUMAB. However, 18,189 reports have been filed with the FAERS database.
What Other Side Effects Does DUPILUMAB Cause?
Pruritus (44,279)
Dermatitis atopic (33,670)
Product use in unapproved indication (33,452)
Rash (30,895)
Injection site pain (27,799)
Drug ineffective (23,712)
Dry skin (20,239)
Eczema (20,020)
Condition aggravated (16,459)
Arthralgia (15,176)
What Other Drugs Cause Product dose omission issue?
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
GOLIMUMAB (4,216)
Which DUPILUMAB Alternatives Have Lower Product dose omission issue Risk?
DUPILUMAB vs DURAGESIC
DUPILUMAB vs DUROGESIC
DUPILUMAB vs DUROTEP MT
DUPILUMAB vs DURVALUMAB
DUPILUMAB vs DUTASTERIDE